Consensus Valeo Pharma Inc. Canadian Securities Exchange

Equities

VPH

CA91915B1085

Delayed Canadian Securities Exchange Other stock markets 20:57:37 28/03/2022 BST			5-day change	1st Jan Change
0.66 ^CAD	-.--%		+1.54%	-10.81%

04-25	Transcript : Valeo Pharma Inc. - Shareholder/Analyst Call
03-22	Valeo Pharma Inc. Announces Appointment of Al Moghaddam to Board of Directors	CI

Evolution of the average Target Price on Valeo Pharma Inc.

Price target over the last 5 years

History of analyst recommendation changes

4ebdddfed877897057958414d5e.OtyXdlMbtjDCPdpm2gxscuB5B6mMZLRT4JCtTOAnAjE.daXWJSFIhEWASoNX7FYUC6c7WMb4XPgng-LjCJpmSVINmPkTPS3yQali7g~59964fdf17276903bc50d20e25529851

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.095 CAD

Average target price

0.5 CAD

Spread / Average Target

+426.32%

High Price Target

0.6 CAD

Spread / Highest target

+531.58%

Low Price Target

0.4 CAD

Spread / Lowest Target

+321.05%

Consensus detail

Consensus revision (last 18 months)

Ratings for Valeo Pharma Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar